文献速递腹部MR

钆塞酸二钠增强MRI序列测量肝脏病灶大小的比较及其对LI-RADS分类的影响

Comparison of gadoxetate disodium-enhanced MRI sequences for measuring hepatic observation size and its implication of LI-RADS classification.
PubMed 文献 · Abdom Radiol (NY) · 2022-01-12

回顾性纳入253例患者279个肝脏病灶,比较6种钆塞酸二钠增强MRI序列显示与测量病灶大小,并与病理测量对照。肝胆期显示评分最高(4.1±0.6)、相关系数最高(r=0.965),移行期绝对差最小(2.3 mm±2.2),其次为肝胆期(2.4 mm±2.1)。LR-3、LR-4、LR-5分类在6种序列间无显著差异(p≥0.122)。

要点

  • 肝胆期显示评分最高(4.1±0.6),且无不可见病灶,与病理测量相关系数最高(r=0.965)。
  • 移行期与病理测量的绝对差最小(2.3 mm±2.2),肝胆期次之(2.4 mm±2.1)。
  • LR-3、LR-4、LR-5分类在6种MRI序列间无显著差异(p≥0.122)。

核心结论

  • 肝胆期图像在钆塞酸二钠增强MRI上测量肝脏病灶具有临床实用性,尤其在病灶可见性和与病理结果的相关性方面。

研究设计与样本

  • 回顾性纳入253例患者共279个肝脏病灶,均行钆塞酸二钠增强MRI并接受肝切除术;两位放射科医师独立在6种序列(T1加权、T2加权、动脉期、门静脉期、移行期、肝胆期)上评估病灶显示评分(5分制)和大小并赋予LI-RADS分类,以病理测量为参考标准。

诊断标准与关键数值

  • 肝胆期显示评分最高(4.1±0.6),与病理测量相关系数最高(r=0.965);与病理测量的绝对差在移行期最低(2.3 mm±2.2),其次为肝胆期(2.4 mm±2.1);LI-RADS分类中肝胆期无不可见病灶,LR-3、LR-4、LR-5分类在6种序列间无显著差异(p≥0.122)。

临床应用与阅片要点

  • 作者结论认为肝胆期图像在钆塞酸二钠增强MRI上测量肝脏病灶具有临床实用性,尤其在病灶可见性和与病理结果的相关性方面。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: We aimed to determine the optimal image sequence for measurement of hepatic observations on gadoxetate disodium-enhanced MRI in comparison with pathologic measurement, and to evaluate its clinical impact on the Liver Imaging Reporting and Data System (LI-RADS) v2018 classification.

METHODS: Two hundred and fifty-three patients (279 hepatic observations) who underwent gadoxetate disodium-enhanced MRI and subsequent hepatectomy were retrospectively included. Two radiologists independently evaluated the visualization score (five-point scale) and size of each observation on six MRI sequences (T1-weighted, T2-weighted, arterial-phase, portal venous-phase, transitional-phase [TP], and hepatobiliary-phase [HBP] images) and assigned a LI-RADS category. Correlations between MRI and pathologic measurements were evaluated using Pearson correlation coefficients. A repeated measures analysis of variance with Bonferroni post hoc comparison tests was used to compare the visualization scores and absolute differences between MRI sequences and pathologic measurements. The LI-RADS classification according the size measurement of each MRI sequence was compared using Cochran's Q test with a post hoc McNemar's test.

RESULTS: Of the MRI sequences, HBP had the highest visualization score (4.1 ± 0.6) and correlation coefficient (r = 0.965). The absolute difference between MRI and pathologic measurement was lowest on TP (2.3 mm ± 2.2), followed by HBP (2.4 mm ± 2.1). In the LI-RADS classifications, HBP did not have any non-visible observations. Regarding LR-3, LR-4, and LR-5, there was no significantly different LI-RADS classification among the six MRI sequences (p ≥ 0.122).

CONCLUSION: Hepatobiliary-phase images are clinically useful for measuring hepatic observations on gadoxetate disodium-enhanced MRI, especially regarding visibility and correlation with pathologic findings.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Choi, Ha, Choi, et al. Comparison of gadoxetate disodium-enhanced MRI sequences for measuring hepatic observation size and its implication of LI-RADS classification. Abdom Radiol (NY). 2022. PMID: 35020008. doi:10.1007/s00261-021-03403-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。